Equifax Inc.
168.09USD
-3.5300 (-2.06%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.23▼ | $2.27 | 1 | 16 |
| Next quarter | $2.23▼ | $2.3 | 2 | 16 |
| Current year | $8.56▼ | $8.6 | 0 | 1 |
| Next year | $10.17▼ | $10.28 | 0 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.2 | $2.25 | +0.05 (+2.3%) |
| 2026-03-31 | $1.7 | $1.86 | +0.16 (+9.7%) |
| 2025-12-31 | $2.05 | $2.09 | +0.04 (+1.8%) |
| 2025-09-30 | $1.94 | $2.04 | +0.10 (+5.3%) |
324 ratings from 33 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Rothschild & Co | Upgraded from Neutral | Buy | $214 $235 | Aug 21, 2026 |
| Wells Fargo | Maintained | Overweight | $220 $212 | Jul 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $243 $225 | Jul 22, 2026 |
| Baird | Maintained | Outperform | $245 $232 | Jul 22, 2026 |
| RBC Capital | Maintained | Outperform | $222 $194 | Jul 22, 2026 |
| Barclays | Maintained | Equal-Weight | $215 $200 | Jul 22, 2026 |
| Needham | Maintained | Buy | $265 $245 | Jul 22, 2026 |
| UBS | Reiterated | Buy | $220 | Jul 8, 2026 |
| Needham | Reiterated | Buy | $265 | Jul 7, 2026 |
| Mizuho | Maintained | Outperform | $222 $210 | Jul 2, 2026 |
| UBS | Maintained | Buy | $215 $220 | Jul 2, 2026 |
| Wells Fargo | Maintained | Overweight | $230 $220 | Jun 18, 2026 |
| UBS | Maintained | Buy | $212 $215 | Jun 16, 2026 |
| B of A Securities | Maintained | Buy | $250 $225 | May 19, 2026 |
| Needham | Reiterated | Buy | $265 | Apr 27, 2026 |
| UBS | Maintained | Buy | $245 $220 | Apr 23, 2026 |
| Wells Fargo | Maintained | Overweight | $240 $230 | Apr 22, 2026 |
| Baird | Maintained | Outperform | $250 $245 | Apr 22, 2026 |
| Needham | Reiterated | Buy | $265 | Apr 22, 2026 |
| Mizuho | Initiated | Outperform | $222 | Apr 16, 2026 |
| UBS | Maintained | Buy | $230 $220 | Apr 13, 2026 |
| Goldman Sachs | Maintained | Neutral | $235 $208 | Feb 9, 2026 |
| JP Morgan | Maintained | Overweight | $260 $230 | Feb 5, 2026 |
| Stifel | Maintained | Buy | $253 $235 | Feb 5, 2026 |
| Barclays | Maintained | Equal-Weight | $240 $215 | Feb 5, 2026 |
102 filings from 24 insiders · 12 buy / 5 sell over 6m
Officers and directors of EFX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| GAMBLE JOHN W JROfficer, EVP, CFO & COO | Sell | 4.5k | $187.96 | $846k | Sep 3, 2026 |
| BEGOR MARK W.Chief Executive Officer | Exercise | 37.8k | $112.46 | $4.25M | Jul 24, 2026 |
| BEGOR MARK W.Chief Executive Officer | Sell | 37.8k | $168.47 | $6.51M | Jul 24, 2026 |
| BORTON CHAD MOfficer | Sell | 2.5k | $173.89 | $427k | May 7, 2026 |
| SMITH MELISSA DEEDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MARCUS ROBERT DDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MCKINLEY JOHN A JRDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MCGREGOR SCOTT ADirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| FEIDLER MARK LDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| LARSON BARBARA ADirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| FICHUK KAREN LINNDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| TILLMAN AUDREY BOONEDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| HOUGH G THOMASDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| GAMBLE JOHN W JRChief Operating Officer | Sell | 3.5k | $176.54 | $618k | May 1, 2026 |
| BEGOR MARK W.Chief Executive Officer | Exercise | 37.8k | $112.46 | $4.25M | Apr 24, 2026 |
| BEGOR MARK W.Chief Executive Officer | Sell | 37.8k | $171.57 | $6.52M | Apr 24, 2026 |
| SMITH DAVID JOHNOfficer | Grant | 23.0k | — | — | Mar 2, 2026 |
| BEGOR MARK W.Chief Executive Officer | Grant | 41.0k | — | — | Feb 25, 2026 |
| GRIGGS JAMES M.Officer | Grant | 1.6k | — | — | Feb 25, 2026 |
| BINDAL SUNILOfficer | Grant | 4.8k | — | — | Feb 25, 2026 |
No analyst notes on EFX yet.
Analyst Ratings
21 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 13 | 6 | 0 | 0 | Buy2.04 |
| 1 mo ago | 4 | 13 | 7 | 0 | 0 | Buy2.13 |
| 2 mo ago | 4 | 12 | 8 | 0 | 0 | Buy2.17 |
| 3 mo ago | 5 | 12 | 7 | 0 | 0 | Buy2.08 |